Dalhousie research team prepares for clinical trial of COVID-19 vaccine.Phase 1 of human clinical trials could begin in the next 3 weeks

Dalhousie’s COVID-19 rapid response team is moving forward with testing a vaccine that uses a genome of DNA from SARS CoV-2, the virus that causes COVID-19.